> top > docs > PMC:3218875 > spans > 30575-32131 > annotations

PMC:3218875 / 30575-32131 JSONTXT

Annnotations TAB JSON ListView MergeView

testone

Id Subject Object Predicate Lexical cue
T17356 1359-1369 Gene_expression denotes expression
T17355 1109-1119 Gene_expression denotes production
T17354 1097-1104 Positive_regulation denotes promote
T17353 934-941 Negative_regulation denotes prevent
T17352 883-897 Positive_regulation denotes overexpression
T17351 694-703 Gene_expression denotes producing
T17350 662-675 Gene_expression denotes overexpressed
T17349 492-501 Gene_expression denotes expressed
T17348 377-383 Binding denotes target
T17347 114-121 Positive_regulation denotes induced
T17336 1179-1186 Protein denotes miR-155
T17335 1105-1108 Protein denotes TNF
T17334 1076-1083 Protein denotes miR-155
T17333 875-882 Protein denotes miR-155
T17332 789-797 Protein denotes miR-146a
T17331 688-693 Protein denotes IL-17
T17330 679-682 Protein denotes CD4
T17329 645-653 Protein denotes miR-146a
T17328 480-487 Protein denotes miR-155
T17327 440-444 Protein denotes RIP1
T17326 431-435 Protein denotes IKKε
T17325 356-363 Protein denotes miR-155
T17324 319-327 Protein denotes miR-146a
T17323 278-283 Protein denotes TRAF6
T17322 268-273 Protein denotes IRAK1
T17321 196-204 Protein denotes miR-146a
T17320 161-164 Protein denotes TNF
T17319 154-159 Protein denotes IL-1β
T17318 15-22 Protein denotes miR-155
T17317 9-10 Protein denotes b
T17316 0-8 Protein denotes miR-146a
R11370 T17316 T17347 themeOf miR-146a,induced
R11371 T17318 T17347 themeOf miR-155,induced
R11372 T17319 T17347 causeOf IL-1β,induced
R11373 T17320 T17347 causeOf TNF,induced
R11374 T17325 T17348 themeOf miR-155,target
R11375 T17326 T17348 themeOf IKKε,target
R11376 T17327 T17348 themeOf RIP1,target
R11377 T17328 T17349 themeOf miR-155,expressed
R11378 T17329 T17350 themeOf miR-146a,overexpressed
R11379 T17331 T17351 themeOf IL-17,producing
R11380 T17333 T17352 themeOf miR-155,overexpression
R11381 T17334 T17354 causeOf miR-155,promote
R11382 T17335 T17355 themeOf TNF,production
R11390 T17355 T17354 themeOf production,promote

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T18382 1555-1556 . denotes .
T18381 1549-1555 NN denotes cohort
T18380 1536-1548 JJ denotes well-defined
T18379 1532-1535 CC denotes and
T18378 1526-1531 JJ denotes large
T18377 1524-1525 DT denotes a
T18376 1518-1523 VBG denotes using
T18375 1505-1517 NN denotes confirmation
T18374 1497-1504 VB denotes require
T18373 1492-1496 MD denotes will
T18372 1487-1491 DT denotes this
T18371 1483-1486 CC denotes but
T18370 1481-1482 , denotes ,
T18369 1480-1481 NNP denotes ]
T18368 1478-1480 CD denotes 88
T18367 1477-1478 NNP denotes [
T18366 1468-1476 NN denotes efficacy
T18365 1458-1467 NN denotes treatment
T18364 1455-1457 CC denotes or
T18363 1453-1454 , denotes ,
T18362 1442-1453 NN denotes progression
T18361 1440-1441 , denotes ,
T18360 1431-1440 NN denotes diagnosis
T18359 1423-1430 NN denotes disease
T18358 1419-1422 IN denotes for
T18357 1412-1418 NN denotes marker
T18356 1410-1411 DT denotes a
T18355 1407-1409 IN denotes as
T18354 1400-1406 JJ denotes useful
T18353 1388-1399 RB denotes potentially
T18352 1385-1387 VBZ denotes is
T18351 1376-1384 NNS denotes patients
T18350 1373-1375 NNP denotes RA
T18349 1370-1372 IN denotes in
T18348 1359-1369 NN denotes expression
T18347 1349-1358 VBN denotes increased
T18346 1343-1348 PRP$ denotes their
T18345 1341-1342 , denotes ,
T18344 1333-1341 NN denotes addition
T18343 1330-1332 IN denotes In
T18342 1328-1329 . denotes .
T18341 1317-1328 JJ denotes substantial
T18340 1314-1316 VBZ denotes is
T18339 1303-1313 NNS denotes treatments
T18338 1299-1302 JJ denotes new
T18337 1296-1298 IN denotes of
T18336 1284-1295 NN denotes development
T18335 1280-1283 DT denotes the
T18334 1276-1279 IN denotes for
T18333 1266-1275 NN denotes potential
T18332 1260-1265 PRP$ denotes their
T18331 1256-1259 CC denotes and
T18330 1253-1255 NNP denotes RA
T18329 1250-1252 IN denotes in
T18328 1237-1249 NN denotes inflammation
T18327 1234-1236 IN denotes of
T18326 1223-1233 NNS denotes regulators
T18325 1214-1222 JJ denotes negative
T18324 1204-1213 JJ denotes important
T18323 1201-1203 VB denotes be
T18322 1191-1200 RB denotes therefore
T18321 1187-1190 MD denotes may
T18320 1179-1186 NN denotes miR-155
T18319 1175-1178 CC denotes and
T18318 1167-1174 NN denotes miR-146
T18317 1165-1166 . denotes .
T18316 1164-1165 NNP denotes ]
T18315 1162-1164 CD denotes 87
T18314 1161-1162 NNP denotes [
T18313 1158-1160 NNP denotes RA
T18312 1155-1157 IN denotes of
T18311 1142-1154 NN denotes pathogenesis
T18310 1138-1141 DT denotes the
T18309 1135-1137 IN denotes in
T18308 1127-1134 NN denotes process
T18307 1123-1126 JJ denotes key
T18306 1121-1122 DT denotes a
T18305 1119-1120 , denotes ,
T18304 1109-1119 NN denotes production
T18303 1105-1108 NNP denotes TNF
T18302 1097-1104 VB denotes promote
T18301 1094-1096 TO denotes to
T18300 1088-1093 VBN denotes shown
T18299 1084-1087 VBD denotes was
T18298 1076-1083 NN denotes miR-155
T18297 1074-1075 , denotes ,
T18296 1066-1074 RB denotes Moreover
T18295 1064-1065 . denotes .
T18294 1063-1064 NNP denotes ]
T18293 1061-1063 CD denotes 81
T18292 1060-1061 NNP denotes [
T18278 946-949 NNP denotes TLR
T18277 942-945 DT denotes the
T18276 934-941 VB denotes prevent
T18275 931-933 TO denotes to
T18274 926-930 JJ denotes able
T18273 922-925 VBD denotes was
T18272 910-921 NNS denotes fibroblasts
T18271 901-909 JJ denotes synovial
T18270 898-900 IN denotes in
T18269 883-897 NN denotes overexpression
T18268 875-882 NN denotes miR-155
T18267 873-874 . denotes .
T18266 872-873 NNP denotes ]
T18265 870-872 CD denotes 86
T18264 869-870 NNP denotes [
T18263 854-868 NN denotes susceptibility
T18262 851-853 NNP denotes RA
T18261 846-850 IN denotes with
T18260 835-845 VBN denotes associated
T18259 832-834 VB denotes be
T18258 829-831 TO denotes to
T18257 823-828 VBN denotes shown
T18256 814-822 RB denotes recently
T18255 810-813 VBD denotes was
T18254 805-809 NN denotes gene
T18253 798-804 NN denotes target
T18252 789-797 NN denotes miR-146a
T18251 785-788 DT denotes the
T18250 782-784 IN denotes of
T18249 778-781 NNP denotes UTR
T18248 777-778 : denotes -
T18247 776-777 '' denotes '
T18246 775-776 CD denotes 3
T18245 771-774 DT denotes the
T18244 768-770 IN denotes in
T18243 755-767 NN denotes polymorphism
T18242 753-754 DT denotes a
T18241 751-752 , denotes ,
T18240 738-751 RB denotes Interestingly
T18239 736-737 . denotes .
T18238 735-736 NNP denotes ]
T18237 730-735 CD denotes 84,85
T18236 729-730 NNP denotes [
T18235 720-728 NNS denotes patients
T18234 717-719 NNP denotes RA
T18206 573-574 , denotes ,
T18205 572-573 NNP denotes ]
T18204 567-572 CD denotes 81,82
T18203 566-567 NNP denotes [
T18202 559-565 NN denotes tissue
T18201 550-558 JJ denotes synovial
T18200 546-549 CC denotes and
T18199 534-545 NNS denotes fibroblasts
T18198 525-533 JJ denotes synovial
T18197 522-524 NNP denotes RA
T18196 519-521 IN denotes in
T18195 512-518 NNS denotes levels
T18194 505-511 JJR denotes higher
T18193 502-504 IN denotes at
T18192 492-501 VBN denotes expressed
T18191 488-491 VBP denotes are
T18190 480-487 NNP denotes miR-155
T18189 476-479 CC denotes and
T18188 468-475 NNP denotes miR-146
T18187 463-467 DT denotes both
T18186 461-462 , denotes ,
T18185 454-461 RB denotes Notably
T18184 452-453 . denotes .
T18183 451-452 NNP denotes ]
T18182 446-451 CD denotes 79,80
T18181 445-446 NNP denotes [
T18180 440-444 NNP denotes RIP1
T18179 436-439 CC denotes and
T18178 431-435 NNP denotes IKKε
T18177 421-430 NNS denotes molecules
T18176 410-420 VBG denotes signalling
T18175 404-409 NN denotes NF-κB
T18174 400-403 DT denotes the
T18173 396-399 IN denotes for
T18172 384-395 NNS denotes transcripts
T18171 377-383 VB denotes target
T18170 374-376 TO denotes to
T18169 368-373 VBN denotes shown
T18168 364-367 VBD denotes was
T18167 356-363 NN denotes miR-155
T18166 354-355 , denotes ,
T18165 345-354 RB denotes Similarly
T18164 343-344 . denotes .
T18163 342-343 -RRB- denotes )
T18162 341-342 CD denotes 1
T18161 334-340 NNP denotes Figure
T18160 333-334 -LRB- denotes (
T18159 331-332 NNP denotes ]
T18158 329-331 CD denotes 78
T18157 328-329 NNP denotes [
T18156 319-327 JJ denotes miR-146a
T18155 316-318 IN denotes of
T18154 310-315 NNS denotes genes
T18153 303-309 NN denotes target
T18152 300-302 IN denotes as
T18151 289-299 VBN denotes identified
T18150 284-288 VBD denotes were
T18149 278-283 NNP denotes TRAF6
T18148 274-277 CC denotes and
T18147 268-273 NNP denotes IRAK1
T18146 258-267 NNS denotes molecules
T18145 247-257 VBG denotes signalling
T18144 241-246 NN denotes NF-κB
T18143 237-240 DT denotes the
T18142 233-236 CC denotes and
T18141 231-232 , denotes ,
T18140 227-231 NN denotes gene
T18139 211-226 JJ denotes NF-κB-dependent
T18138 208-210 DT denotes an
T18137 205-207 VBZ denotes is
T18136 196-204 NN denotes miR-146a
T18135 194-195 , denotes ,
T18134 186-194 NN denotes addition
T18133 183-185 IN denotes In
T18132 181-182 . denotes .
T18131 180-181 NNP denotes ]
T18130 175-180 CD denotes 78,79
T18129 174-175 NNP denotes [
T18128 169-173 NNP denotes TLRs
T18127 165-168 CC denotes and
T18126 161-164 NNP denotes TNF
T18125 159-160 , denotes ,
T18124 154-159 NN denotes IL-1β
T18123 151-153 IN denotes as
T18122 146-150 JJ denotes such
T18121 138-145 NNS denotes stimuli
T18120 125-137 JJ denotes inflammatory
T18119 122-124 IN denotes by
T18118 114-121 VBN denotes induced
T18117 111-113 VB denotes be
T18116 107-110 MD denotes can
T18115 100-106 NNS denotes miRNAs
T18114 94-99 DT denotes these
T18113 88-93 IN denotes since
T18112 86-87 , denotes ,
T18111 81-86 NNP denotes NF-κB
T18110 78-80 TO denotes to
T18109 67-77 NN denotes signalling
T18108 54-66 JJ denotes inflammatory
T18107 50-53 IN denotes for
T18106 41-49 NN denotes interest
T18105 30-40 JJ denotes particular
T18104 27-29 IN denotes of
T18103 23-26 VBP denotes are
T18102 15-22 NN denotes miR-155
T18101 11-14 CC denotes and
T18100 9-10 NN denotes b
T18099 8-9 NN denotes /
T18098 0-8 JJ denotes miR-146a
T18233 712-716 IN denotes from
T18232 706-711 NNS denotes cells
T18231 704-705 NN denotes T
T18230 688-703 JJ denotes IL-17-producing
T18229 684-687 CC denotes and
T18228 682-683 NNP denotes +
T18227 679-682 NNP denotes CD4
T18226 676-678 IN denotes in
T18225 662-675 VBN denotes overexpressed
T18224 657-661 RB denotes also
T18223 654-656 VBZ denotes is
T18222 645-653 NN denotes miR-146a
T18221 643-644 . denotes .
T18220 642-643 NNP denotes ]
T18219 640-642 CD denotes 83
T18218 639-640 NNP denotes [
T18217 630-638 NNS denotes patients
T18216 627-629 NNP denotes RA
T18215 624-626 IN denotes of
T18214 618-623 NNS denotes cells
T18213 606-617 NN denotes mononuclear
T18212 600-605 NN denotes blood
T18211 589-599 JJ denotes peripheral
T18210 586-588 IN denotes in
T18209 583-585 IN denotes as
T18208 578-582 RB denotes well
T18207 575-577 RB denotes as
T18291 1057-1059 NNP denotes RA
T18290 1054-1056 IN denotes in
T18289 1042-1053 NN denotes destruction
T18288 1035-1041 NN denotes tissue
T18287 1027-1034 VBP denotes mediate
T18286 1022-1026 WDT denotes that
T18285 1003-1021 NNS denotes metalloproteinases
T18284 996-1002 NN denotes matrix
T18283 987-995 JJ denotes specific
T18282 984-986 IN denotes of
T18281 973-983 NN denotes expression
T18280 954-972 JJ denotes cytokine-inducible
T18279 950-953 CC denotes and
R11954 T18098 T18100 amod miR-146a,b
R11955 T18099 T18100 compound /,b
R11956 T18100 T18103 nsubj b,are
R11957 T18101 T18100 cc and,b
R11958 T18102 T18100 conj miR-155,b
R11959 T18103 T18103 ROOT are,are
R11960 T18104 T18103 prep of,are
R11961 T18105 T18106 amod particular,interest
R11962 T18106 T18104 pobj interest,of
R11963 T18107 T18103 prep for,are
R11964 T18108 T18109 amod inflammatory,signalling
R11965 T18109 T18107 pobj signalling,for
R11966 T18110 T18109 prep to,signalling
R11967 T18111 T18110 pobj NF-κB,to
R11968 T18112 T18103 punct ",",are
R11969 T18113 T18118 mark since,induced
R11970 T18114 T18115 det these,miRNAs
R11971 T18115 T18118 nsubjpass miRNAs,induced
R11972 T18116 T18118 aux can,induced
R11973 T18117 T18118 auxpass be,induced
R11974 T18118 T18103 advcl induced,are
R11975 T18119 T18118 agent by,induced
R11976 T18120 T18121 amod inflammatory,stimuli
R11977 T18121 T18119 pobj stimuli,by
R11978 T18122 T18123 amod such,as
R11979 T18123 T18121 prep as,stimuli
R11980 T18124 T18123 pobj IL-1β,as
R11981 T18125 T18124 punct ",",IL-1β
R11982 T18126 T18124 conj TNF,IL-1β
R11983 T18127 T18126 cc and,TNF
R11984 T18128 T18129 compound TLRs,[
R11985 T18129 T18126 conj [,TNF
R11986 T18130 T18131 compound "78,79",]
R11987 T18131 T18126 conj ],TNF
R11988 T18132 T18103 punct .,are
R11989 T18133 T18137 prep In,is
R11990 T18134 T18133 pobj addition,In
R11991 T18135 T18137 punct ",",is
R11992 T18136 T18137 nsubj miR-146a,is
R11993 T18137 T18137 ROOT is,is
R11994 T18138 T18140 det an,gene
R11995 T18139 T18140 amod NF-κB-dependent,gene
R11996 T18140 T18137 attr gene,is
R11997 T18141 T18137 punct ",",is
R11998 T18142 T18137 cc and,is
R11999 T18143 T18144 det the,NF-κB
R12000 T18144 T18145 nsubj NF-κB,signalling
R12001 T18145 T18151 advcl signalling,identified
R12002 T18146 T18145 dobj molecules,signalling
R12003 T18147 T18151 nsubjpass IRAK1,identified
R12004 T18148 T18147 cc and,IRAK1
R12005 T18149 T18147 conj TRAF6,IRAK1
R12006 T18150 T18151 auxpass were,identified
R12007 T18151 T18137 conj identified,is
R12008 T18152 T18151 prep as,identified
R12009 T18153 T18154 compound target,genes
R12010 T18154 T18152 pobj genes,as
R12011 T18155 T18154 prep of,genes
R12012 T18156 T18157 compound miR-146a,[
R12013 T18157 T18155 pobj [,of
R12014 T18158 T18159 nummod 78,]
R12015 T18159 T18154 conj ],genes
R12016 T18160 T18161 punct (,Figure
R12017 T18161 T18159 appos Figure,]
R12018 T18162 T18161 nummod 1,Figure
R12019 T18163 T18159 punct ),]
R12020 T18164 T18151 punct .,identified
R12021 T18165 T18169 advmod Similarly,shown
R12022 T18166 T18169 punct ",",shown
R12023 T18167 T18169 nsubjpass miR-155,shown
R12024 T18168 T18169 auxpass was,shown
R12025 T18169 T18169 ROOT shown,shown
R12026 T18170 T18171 aux to,target
R12027 T18171 T18169 xcomp target,shown
R12028 T18172 T18171 dobj transcripts,target
R12029 T18173 T18172 prep for,transcripts
R12030 T18174 T18175 det the,NF-κB
R12031 T18175 T18176 nsubj NF-κB,signalling
R12032 T18176 T18173 pcomp signalling,for
R12033 T18177 T18176 dobj molecules,signalling
R12034 T18178 T18176 dobj IKKε,signalling
R12035 T18179 T18178 cc and,IKKε
R12036 T18180 T18181 compound RIP1,[
R12037 T18181 T18178 conj [,IKKε
R12038 T18182 T18183 compound "79,80",]
R12039 T18183 T18178 conj ],IKKε
R12040 T18184 T18169 punct .,shown
R12041 T18185 T18192 advmod Notably,expressed
R12042 T18186 T18192 punct ",",expressed
R12043 T18187 T18188 preconj both,miR-146
R12044 T18188 T18192 nsubjpass miR-146,expressed
R12045 T18189 T18188 cc and,miR-146
R12046 T18190 T18188 conj miR-155,miR-146
R12047 T18191 T18192 auxpass are,expressed
R12048 T18192 T18192 ROOT expressed,expressed
R12049 T18193 T18192 prep at,expressed
R12050 T18194 T18195 amod higher,levels
R12051 T18195 T18193 pobj levels,at
R12052 T18196 T18195 prep in,levels
R12053 T18197 T18196 pobj RA,in
R12054 T18198 T18199 amod synovial,fibroblasts
R12055 T18199 T18195 conj fibroblasts,levels
R12056 T18200 T18199 cc and,fibroblasts
R12057 T18201 T18202 amod synovial,tissue
R12058 T18202 T18205 compound tissue,]
R12059 T18203 T18205 compound [,]
R12060 T18204 T18205 compound "81,82",]
R12061 T18205 T18199 conj ],fibroblasts
R12062 T18206 T18205 punct ",",]
R12063 T18207 T18209 advmod as,as
R12064 T18208 T18209 advmod well,as
R12065 T18209 T18193 cc as,at
R12066 T18210 T18209 prep in,as
R12067 T18211 T18214 amod peripheral,cells
R12068 T18212 T18213 compound blood,mononuclear
R12069 T18213 T18214 compound mononuclear,cells
R12070 T18214 T18210 pobj cells,in
R12071 T18215 T18214 prep of,cells
R12072 T18216 T18217 compound RA,patients
R12073 T18217 T18215 pobj patients,of
R12074 T18218 T18220 nmod [,]
R12075 T18219 T18220 nummod 83,]
R12076 T18220 T18192 dobj ],expressed
R12077 T18221 T18192 punct .,expressed
R12078 T18222 T18225 nsubjpass miR-146a,overexpressed
R12079 T18223 T18225 auxpass is,overexpressed
R12080 T18224 T18225 advmod also,overexpressed
R12081 T18225 T18225 ROOT overexpressed,overexpressed
R12082 T18226 T18225 prep in,overexpressed
R12083 T18227 T18228 compound CD4,+
R12084 T18228 T18226 pobj +,in
R12085 T18229 T18228 cc and,+
R12086 T18230 T18228 conj IL-17-producing,+
R12087 T18231 T18232 compound T,cells
R12088 T18232 T18225 conj cells,overexpressed
R12089 T18233 T18232 prep from,cells
R12090 T18234 T18235 compound RA,patients
R12091 T18235 T18233 pobj patients,from
R12092 T18236 T18237 quantmod [,"84,85"
R12093 T18237 T18238 nummod "84,85",]
R12094 T18238 T18232 conj ],cells
R12095 T18239 T18225 punct .,overexpressed
R12096 T18240 T18257 advmod Interestingly,shown
R12097 T18241 T18257 punct ",",shown
R12098 T18242 T18243 det a,polymorphism
R12099 T18243 T18257 nsubjpass polymorphism,shown
R12100 T18244 T18243 prep in,polymorphism
R12101 T18245 T18249 det the,UTR
R12102 T18246 T18249 nummod 3,UTR
R12103 T18247 T18246 punct ',3
R12104 T18248 T18249 punct -,UTR
R12105 T18249 T18244 pobj UTR,in
R12106 T18250 T18249 prep of,UTR
R12107 T18251 T18254 det the,gene
R12108 T18252 T18254 compound miR-146a,gene
R12109 T18253 T18254 compound target,gene
R12110 T18254 T18250 pobj gene,of
R12111 T18255 T18257 auxpass was,shown
R12112 T18256 T18257 advmod recently,shown
R12113 T18257 T18257 ROOT shown,shown
R12114 T18258 T18260 aux to,associated
R12115 T18259 T18260 auxpass be,associated
R12116 T18260 T18257 xcomp associated,shown
R12117 T18261 T18260 prep with,associated
R12118 T18262 T18263 compound RA,susceptibility
R12119 T18263 T18264 compound susceptibility,[
R12120 T18264 T18261 pobj [,with
R12121 T18265 T18266 nummod 86,]
R12122 T18266 T18264 appos ],[
R12123 T18267 T18257 punct .,shown
R12124 T18268 T18269 compound miR-155,overexpression
R12125 T18269 T18273 nsubj overexpression,was
R12127 T18271 T18272 amod synovial,fibroblasts
R12128 T18272 T18270 pobj fibroblasts,in
R12129 T18273 T18273 ROOT was,was
R12130 T18274 T18273 acomp able,was
R12131 T18275 T18276 aux to,prevent
R12132 T18276 T18274 xcomp prevent,able
R12133 T18277 T18278 det the,TLR
R12134 T18278 T18276 dobj TLR,prevent
R12135 T18279 T18278 cc and,TLR
R12136 T18280 T18281 amod cytokine-inducible,expression
R12137 T18281 T18278 conj expression,TLR
R12138 T18282 T18281 prep of,expression
R12139 T18283 T18285 amod specific,metalloproteinases
R12140 T18284 T18285 compound matrix,metalloproteinases
R12141 T18285 T18282 pobj metalloproteinases,of
R12142 T18286 T18287 nsubj that,mediate
R12143 T18287 T18285 relcl mediate,metalloproteinases
R12144 T18288 T18289 amod tissue,destruction
R12145 T18289 T18287 dobj destruction,mediate
R12146 T18290 T18287 prep in,mediate
R12147 T18291 T18292 compound RA,[
R12148 T18292 T18290 pobj [,in
R12149 T18293 T18294 nummod 81,]
R12150 T18294 T18292 appos ],[
R12151 T18295 T18273 punct .,was
R12152 T18296 T18300 advmod Moreover,shown
R12153 T18297 T18300 punct ",",shown
R12154 T18298 T18300 nsubjpass miR-155,shown
R12155 T18299 T18300 auxpass was,shown
R12156 T18300 T18300 ROOT shown,shown
R12157 T18301 T18302 aux to,promote
R12158 T18302 T18300 xcomp promote,shown
R12159 T18303 T18304 compound TNF,production
R12160 T18304 T18302 dobj production,promote
R12161 T18305 T18304 punct ",",production
R12162 T18306 T18308 det a,process
R12163 T18307 T18308 amod key,process
R12164 T18308 T18304 appos process,production
R12165 T18309 T18308 prep in,process
R12166 T18310 T18311 det the,pathogenesis
R12167 T18311 T18309 pobj pathogenesis,in
R12168 T18312 T18311 prep of,pathogenesis
R12169 T18313 T18314 compound RA,[
R12170 T18314 T18312 pobj [,of
R12171 T18315 T18316 nummod 87,]
R12172 T18316 T18311 appos ],pathogenesis
R12173 T18317 T18300 punct .,shown
R12174 T18318 T18323 nsubj miR-146,be
R12175 T18319 T18318 cc and,miR-146
R12176 T18320 T18318 conj miR-155,miR-146
R12177 T18321 T18323 aux may,be
R12178 T18322 T18323 advmod therefore,be
R12179 T18323 T18323 ROOT be,be
R12180 T18324 T18326 amod important,regulators
R12181 T18325 T18326 amod negative,regulators
R12182 T18326 T18323 attr regulators,be
R12183 T18327 T18326 prep of,regulators
R12184 T18328 T18327 pobj inflammation,of
R12185 T18329 T18328 prep in,inflammation
R12186 T18330 T18329 pobj RA,in
R12187 T18331 T18323 cc and,be
R12188 T18332 T18333 poss their,potential
R12189 T18333 T18340 nsubj potential,is
R12190 T18334 T18333 prep for,potential
R12191 T18335 T18336 det the,development
R12192 T18336 T18334 pobj development,for
R12193 T18337 T18336 prep of,development
R12194 T18338 T18339 amod new,treatments
R12195 T18339 T18337 pobj treatments,of
R12196 T18340 T18323 conj is,be
R12197 T18341 T18340 acomp substantial,is
R12198 T18342 T18340 punct .,is
R12199 T18343 T18352 prep In,is
R12200 T18344 T18343 pobj addition,In
R12201 T18345 T18352 punct ",",is
R12202 T18346 T18348 poss their,expression
R12203 T18347 T18348 amod increased,expression
R12204 T18348 T18352 nsubj expression,is
R12205 T18349 T18348 prep in,expression
R12206 T18350 T18351 compound RA,patients
R12207 T18351 T18349 pobj patients,in
R12208 T18352 T18352 ROOT is,is
R12209 T18353 T18354 advmod potentially,useful
R12210 T18354 T18352 acomp useful,is
R12211 T18355 T18354 prep as,useful
R12212 T18356 T18357 det a,marker
R12213 T18357 T18355 pobj marker,as
R12214 T18358 T18357 prep for,marker
R12215 T18359 T18360 compound disease,diagnosis
R12216 T18360 T18358 pobj diagnosis,for
R12217 T18361 T18360 punct ",",diagnosis
R12218 T18362 T18360 conj progression,diagnosis
R12219 T18363 T18362 punct ",",progression
R12220 T18364 T18362 cc or,progression
R12221 T18365 T18366 compound treatment,efficacy
R12222 T18366 T18362 conj efficacy,progression
R12223 T18367 T18369 nmod [,]
R12224 T18368 T18369 nummod 88,]
R12225 T18369 T18357 appos ],marker
R12226 T18370 T18352 punct ",",is
R12227 T18371 T18352 cc but,is
R12228 T18372 T18374 nsubj this,require
R12229 T18373 T18374 aux will,require
R12230 T18374 T18352 conj require,is
R12231 T18375 T18374 dobj confirmation,require
R12232 T18376 T18374 advcl using,require
R12233 T18377 T18381 det a,cohort
R12234 T18378 T18381 amod large,cohort
R12235 T18379 T18378 cc and,large
R12236 T18380 T18378 conj well-defined,large
R12237 T18381 T18376 dobj cohort,using
R12238 T18382 T18374 punct .,require
R12126 T18270 T18269 prep in,overexpression

DLUT931

Id Subject Object Predicate Lexical cue
T18587 1097-1104 Positive_regulation denotes promote
T18586 1109-1119 Gene_expression denotes production
T18585 883-897 Positive_regulation denotes overexpression
T18584 694-703 Gene_expression denotes producing
T18583 662-675 Gene_expression denotes overexpressed
T18582 492-501 Gene_expression denotes expressed
T18581 211-226 Regulation denotes NF-κB-dependent
T18571 1179-1186 Protein denotes miR-155
T18564 645-653 Protein denotes miR-146a
T18563 480-487 Protein denotes miR-155
T18562 440-444 Protein denotes RIP1
T18561 431-435 Protein denotes IKKε
T18560 356-363 Protein denotes miR-155
T18559 319-327 Protein denotes miR-146a
T18558 278-283 Protein denotes TRAF6
T18557 268-273 Protein denotes IRAK1
T18556 196-204 Protein denotes miR-146a
T18555 161-164 Protein denotes TNF
T18554 154-159 Protein denotes IL-1β
T18553 15-22 Protein denotes miR-155
T18552 9-10 Protein denotes b
T18551 0-8 Protein denotes miR-146a
T18570 1105-1108 Protein denotes TNF
T18569 1076-1083 Protein denotes miR-155
T18568 875-882 Protein denotes miR-155
T18567 789-797 Protein denotes miR-146a
T18566 688-693 Protein denotes IL-17
T18565 679-682 Protein denotes CD4
R12374 T18556 T18581 themeOf miR-146a,NF-κB-dependent
R12375 T18563 T18582 themeOf miR-155,expressed
R12376 T18564 T18583 themeOf miR-146a,overexpressed
R12377 T18565 T18584 themeOf CD4,producing
R12378 T18566 T18584 themeOf IL-17,producing
R12379 T18568 T18585 themeOf miR-155,overexpression
R12380 T18569 T18587 causeOf miR-155,promote
R12381 T18570 T18586 themeOf TNF,production
R12389 T18586 T18587 themeOf production,promote

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T18507 688-693 http://www.uniprot.org/uniprot/Q16552 denotes IL-17
T18506 679-682 http://www.uniprot.org/uniprot/P01730 denotes CD4
T18505 440-444 http://www.uniprot.org/uniprot/Q13546 denotes RIP1
T18504 278-283 http://www.uniprot.org/uniprot/Q9Y4K3 denotes TRAF6
T18503 1105-1108 http://www.uniprot.org/uniprot/P01375 denotes TNF
T18502 161-164 http://www.uniprot.org/uniprot/P01375 denotes TNF
T18501 154-159 http://www.uniprot.org/uniprot/P01584 denotes IL-1β

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T17520 278-283 Protein denotes TRAF6
T17519 268-273 Protein denotes IRAK1
T17518 196-204 Protein denotes miR-146a
T17517 161-164 Protein denotes TNF
T17516 154-159 Protein denotes IL-1β
T17515 15-22 Protein denotes miR-155
T17514 9-10 Protein denotes b
T17513 0-8 Protein denotes miR-146a
T17533 1179-1186 Protein denotes miR-155
T17532 1105-1108 Protein denotes TNF
T17531 1076-1083 Protein denotes miR-155
T17530 875-882 Protein denotes miR-155
T17529 789-797 Protein denotes miR-146a
T17528 688-693 Protein denotes IL-17
T17527 679-682 Protein denotes CD4
T17526 645-653 Protein denotes miR-146a
T17525 480-487 Protein denotes miR-155
T17524 440-444 Protein denotes RIP1
T17523 431-435 Protein denotes IKKε
T17522 356-363 Protein denotes miR-155
T17521 319-327 Protein denotes miR-146a

bionlp-st-ge-2016-coref

Id Subject Object Predicate Lexical cue
T17512 1179-1186 Antecedent denotes miR-155
T17511 1343-1348 Anaphor denotes their
T17510 15-22 Antecedent denotes miR-155
T17509 94-106 Anaphor denotes these miRNAs
R11438 T17509 T17510 boundBy these miRNAs,miR-155
R11439 T17511 T17512 boundBy their,miR-155

2_test

Id Subject Object Predicate Lexical cue
21639951-16885212-4289510 175-177 16885212 denotes 78
21639951-17242365-4289511 178-180 17242365 denotes 79
21639951-16885212-4289512 329-331 16885212 denotes 78
21639951-17242365-4289513 446-448 17242365 denotes 79
21639951-17911593-4289514 449-451 17911593 denotes 80
21639951-18383392-4289515 567-569 18383392 denotes 81
21639951-18438844-4289516 570-572 18438844 denotes 82
21639951-18759964-4289517 640-642 18759964 denotes 83
21639951-20459811-4289518 730-732 20459811 denotes 84
21639951-20870441-4289519 870-872 20870441 denotes 86
21639951-18383392-4289520 1061-1063 18383392 denotes 81
21639951-17463289-4289521 1162-1164 17463289 denotes 87
21639951-20470394-4289522 1478-1480 20470394 denotes 88

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T17797 1142-1154 NN denotes pathogenesis
T17796 1138-1141 DT denotes the
T17795 1135-1137 IN denotes in
T17794 1127-1134 NN denotes process
T17793 1123-1126 JJ denotes key
T17792 1121-1122 DT denotes a
T17791 1119-1120 -COMMA- denotes ,
T17790 1109-1119 NN denotes production
T17789 1105-1108 NN denotes TNF
T17788 1097-1104 VB denotes promote
T17787 1094-1096 TO denotes to
T17786 1088-1093 VB denotes shown
T17785 1084-1087 VB denotes was
T17784 1076-1083 NN denotes miR-155
T17783 1074-1075 -COMMA- denotes ,
T17782 1066-1074 RB denotes Moreover
T17781 1038-1039 -RRB- denotes s
T17780 1036-1038 CD denotes is
T17779 1035-1036 -LRB- denotes t
T17778 1033-1035 NN denotes e
T17777 1031-1033 IN denotes at
T17776 1020-1031 NN denotes s that medi
T17775 1014-1020 NN denotes einase
T17774 1007-1014 VB denotes lloprot
T17773 1003-1007 WDT denotes meta
T17772 984-1002 NN denotes of specific matrix
T17771 978-984 NN denotes ssion
T17770 970-978 JJ denotes le expre
T17769 968-970 IN denotes ib
T17768 958-968 NN denotes kine-induc
T17767 940-958 JJ denotes t the TLR and cyto
T17766 937-940 CC denotes ven
T17765 934-937 NN denotes pre
T17764 931-934 DT denotes to
T17763 924-931 VB denotes s able
T17762 922-924 TO denotes wa
T17761 918-922 JJ denotes sts
T17760 915-918 VB denotes bla
T17759 904-915 NN denotes ovial fibro
T17758 896-904 JJ denotes n in syn
T17757 894-896 IN denotes io
T17756 880-894 NN denotes 55 overexpress
T17755 873-880 NN denotes . miR-1
T17754 872-873 -RRB- denotes ]
T17753 870-872 CD denotes 86
T17752 869-870 -LRB- denotes [
T17751 854-868 NN denotes susceptibility
T17750 851-853 NN denotes RA
T17749 846-850 IN denotes with
T17748 835-845 VB denotes associated
T17747 832-834 VB denotes be
T17746 829-831 TO denotes to
T17745 823-828 VB denotes shown
T17744 814-822 RB denotes recently
T17743 810-813 VB denotes was
T17742 805-809 NN denotes gene
T17741 798-804 NN denotes target
T17740 789-797 NN denotes miR-146a
T17739 785-788 DT denotes the
T17738 782-784 IN denotes of
T17737 775-781 NN denotes 3'-UTR
T17736 771-774 DT denotes the
T17735 768-770 IN denotes in
T17734 755-767 NN denotes polymorphism
T17733 753-754 DT denotes a
T17732 751-752 -COMMA- denotes ,
T17731 738-751 RB denotes Interestingly
T17730 723-724 -RRB- denotes i
T17729 718-723 CD denotes A pat
T17728 717-718 -LRB- denotes R
T17727 708-716 NN denotes lls from
T17726 706-708 NN denotes ce
T17725 701-705 IN denotes ng T
T17724 696-701 NN denotes oduci
T17723 695-696 NN denotes r
T17722 680-695 JJ denotes D4+ and IL-17-p
T17721 677-680 CC denotes n C
T17720 673-677 JJ denotes ed i
T17719 671-673 IN denotes ss
T17718 658-671 VB denotes lso overexpre
T17717 654-658 RB denotes is a
T17716 651-653 VB denotes 6a
T17715 643-651 NN denotes . miR-14
T17714 642-643 -RRB- denotes ]
T17713 640-642 CD denotes 83
T17712 639-640 -LRB- denotes [
T17711 630-638 NN denotes patients
T17710 627-629 NN denotes RA
T17709 624-626 IN denotes of
T17708 618-623 NN denotes cells
T17707 606-617 JJ denotes mononuclear
T17706 600-605 NN denotes blood
T17705 589-599 JJ denotes peripheral
T17704 586-588 IN denotes in
T17703 583-585 IN denotes as
T17702 578-582 RB denotes well
T17701 575-577 RB denotes as
T17700 573-574 -COMMA- denotes ,
T17699 572-573 -RRB- denotes ]
T17698 567-572 CD denotes 81,82
T17697 566-567 -LRB- denotes [
T17696 559-565 NN denotes tissue
T17695 550-558 JJ denotes synovial
T17694 546-549 CC denotes and
T17693 534-545 NN denotes fibroblasts
T17692 525-533 JJ denotes synovial
T17691 522-524 NN denotes RA
T17690 519-521 IN denotes in
T17689 512-518 NN denotes levels
T17688 505-511 JJ denotes higher
T17687 502-504 IN denotes at
T17686 492-501 VB denotes expressed
T17685 488-491 VB denotes are
T17684 480-487 NN denotes miR-155
T17683 476-479 CC denotes and
T17682 468-475 NN denotes miR-146
T17681 463-467 CC denotes both
T17680 461-462 -COMMA- denotes ,
T17679 454-461 RB denotes Notably
T17678 451-452 -RRB- denotes ]
T17677 446-451 CD denotes 79,80
T17676 445-446 -LRB- denotes [
T17675 440-444 NN denotes RIP1
T17674 436-439 CC denotes and
T17673 431-435 NN denotes IKKε
T17672 421-430 NN denotes molecules
T17671 410-420 NN denotes signalling
T17670 404-409 NN denotes NF-κB
T17669 400-403 DT denotes the
T17668 396-399 IN denotes for
T17667 384-395 NN denotes transcripts
T17666 377-383 NN denotes target
T17665 374-376 TO denotes to
T17664 368-373 VB denotes shown
T17663 364-367 VB denotes was
T17662 356-363 NN denotes miR-155
T17661 354-355 -COMMA- denotes ,
T17660 345-354 RB denotes Similarly
T17659 342-343 -RRB- denotes )
T17658 341-342 CD denotes 1
T17657 334-340 NN denotes Figure
T17656 333-334 -LRB- denotes (
T17655 331-332 -RRB- denotes ]
T17654 329-331 CD denotes 78
T17653 328-329 -LRB- denotes [
T17652 319-327 NN denotes miR-146a
T17651 316-318 IN denotes of
T17650 310-315 NN denotes genes
T17649 303-309 NN denotes target
T17648 300-302 IN denotes as
T17647 289-299 VB denotes identified
T17646 284-288 VB denotes were
T17645 278-283 NN denotes TRAF6
T17644 274-277 CC denotes and
T17643 268-273 NN denotes IRAK1
T17642 258-267 NN denotes molecules
T17641 247-257 NN denotes signalling
T17640 241-246 NN denotes NF-κB
T17639 237-240 DT denotes the
T17638 233-236 CC denotes and
T17637 231-232 -COMMA- denotes ,
T17636 227-231 NN denotes gene
T17635 211-226 JJ denotes NF-κB-dependent
T17634 208-210 DT denotes an
T17633 205-207 VB denotes is
T17632 196-204 NN denotes miR-146a
T17631 194-195 -COMMA- denotes ,
T17630 186-194 NN denotes addition
T17629 183-185 IN denotes In
T17628 180-181 -RRB- denotes ]
T17627 175-180 CD denotes 78,79
T17626 174-175 -LRB- denotes [
T17625 169-173 NN denotes TLRs
T17624 165-168 CC denotes and
T17623 161-164 NN denotes TNF
T17622 159-160 -COMMA- denotes ,
T17621 154-159 NN denotes IL-1β
T17620 151-153 IN denotes as
T17619 146-150 JJ denotes such
T17618 138-145 NN denotes stimuli
T17617 125-137 JJ denotes inflammatory
T17616 122-124 IN denotes by
T17615 114-121 VB denotes induced
T17614 111-113 VB denotes be
T17613 107-110 MD denotes can
T17612 100-106 NN denotes miRNAs
T17611 94-99 DT denotes these
T17610 88-93 IN denotes since
T17609 86-87 -COMMA- denotes ,
T17608 81-86 NN denotes NF-κB
T17607 78-80 TO denotes to
T17606 67-77 NN denotes signalling
T17605 54-66 JJ denotes inflammatory
T17604 50-53 IN denotes for
T17603 41-49 NN denotes interest
T17602 30-40 JJ denotes particular
T17601 27-29 IN denotes of
T17600 23-26 VB denotes are
T17599 15-22 NN denotes miR-155
T17598 11-14 CC denotes and
T17597 0-10 NN denotes miR-146a/b
T17865 1549-1555 NN denotes cohort
T17864 1536-1548 JJ denotes well-defined
T17863 1532-1535 CC denotes and
T17862 1526-1531 JJ denotes large
T17861 1524-1525 DT denotes a
T17860 1518-1523 VB denotes using
T17859 1505-1517 NN denotes confirmation
T17858 1497-1504 VB denotes require
T17857 1492-1496 MD denotes will
T17856 1487-1491 DT denotes this
T17855 1483-1486 CC denotes but
T17854 1481-1482 -COMMA- denotes ,
T17853 1480-1481 -RRB- denotes ]
T17852 1478-1480 CD denotes 88
T17851 1477-1478 -LRB- denotes [
T17850 1468-1476 NN denotes efficacy
T17849 1458-1467 NN denotes treatment
T17848 1455-1457 CC denotes or
T17847 1453-1454 -COMMA- denotes ,
T17846 1442-1453 NN denotes progression
T17845 1440-1441 -COMMA- denotes ,
T17844 1431-1440 NN denotes diagnosis
T17843 1423-1430 NN denotes disease
T17842 1419-1422 IN denotes for
T17841 1412-1418 NN denotes marker
T17840 1410-1411 DT denotes a
T17839 1407-1409 IN denotes as
T17838 1400-1406 JJ denotes useful
T17837 1388-1399 RB denotes potentially
T17836 1385-1387 VB denotes is
T17835 1376-1384 NN denotes patients
T17834 1373-1375 NN denotes RA
T17833 1370-1372 IN denotes in
T17832 1359-1369 NN denotes expression
T17831 1349-1358 VB denotes increased
T17830 1343-1348 PRP-DOLLAR- denotes their
T17829 1341-1342 -COMMA- denotes ,
T17828 1333-1341 NN denotes addition
T17827 1330-1332 IN denotes In
T17826 1296-1307 JJ denotes of new trea
T17825 1294-1296 VB denotes t
T17824 1284-1294 NN denotes developmen
T17823 1280-1283 JJ denotes the
T17822 1277-1279 IN denotes or
T17821 1266-1277 NN denotes potential f
T17820 1263-1266 DT denotes ir
T17819 1260-1263 IN denotes the
T17818 1250-1259 NN denotes in RA and
T17817 1245-1250 PRP-DOLLAR- denotes tion
T17816 1242-1245 CC denotes mma
T17815 1240-1242 NN denotes la
T17814 1238-1240 IN denotes nf
T17813 1226-1238 NN denotes ulators of i
T17812 1224-1226 IN denotes eg
T17811 1214-1224 NN denotes negative r
T17810 1205-1213 JJ denotes mportant
T17809 1196-1205 JJ denotes fore be i
T17808 1194-1196 VB denotes re
T17807 1185-1194 RB denotes 5 may the
T17806 1182-1185 MD denotes -15
T17805 1175-1182 NN denotes and miR
T17804 1172-1175 CC denotes 46
T17803 1165-1172 NN denotes . miR-1
T17802 1164-1165 -RRB- denotes ]
T17801 1162-1164 CD denotes 87
T17800 1161-1162 -LRB- denotes [
T17799 1158-1160 NN denotes RA
T17798 1155-1157 IN denotes of
R11493 T17597 T17598 arg1Of miR-146a/b,and
R11494 T17598 T17600 arg1Of and,are
R11495 T17598 T17601 arg1Of and,of
R11496 T17599 T17598 arg2Of miR-155,and
R11497 T17600 T17609 arg1Of are,","
R11498 T17600 T17610 arg1Of are,since
R11499 T17601 T17600 arg2Of of,are
R11500 T17603 T17601 arg2Of interest,of
R11501 T17603 T17602 arg1Of interest,particular
R11502 T17603 T17604 arg1Of interest,for
R11503 T17606 T17604 arg2Of signalling,for
R11504 T17606 T17605 arg1Of signalling,inflammatory
R11505 T17606 T17607 arg1Of signalling,to
R11506 T17608 T17607 arg2Of NF-κB,to
R11507 T17612 T17611 arg1Of miRNAs,these
R11508 T17612 T17613 arg1Of miRNAs,can
R11509 T17612 T17614 arg1Of miRNAs,be
R11510 T17612 T17615 arg2Of miRNAs,induced
R11511 T17615 T17610 arg2Of induced,since
R11512 T17615 T17613 arg2Of induced,can
R11513 T17615 T17614 arg2Of induced,be
R11514 T17618 T17615 arg1Of stimuli,induced
R11515 T17618 T17616 arg2Of stimuli,by
R11516 T17618 T17617 arg1Of stimuli,inflammatory
R11517 T17618 T17620 arg1Of stimuli,as
R11518 T17620 T17619 arg1Of as,such
R11519 T17621 T17622 arg1Of IL-1β,","
R11520 T17622 T17624 arg1Of ",",and
R11521 T17623 T17622 arg2Of TNF,","
R11522 T17624 T17620 arg2Of and,as
R11523 T17625 T17624 arg2Of TLRs,and
R11524 T17625 T17626 arg1Of TLRs,[
R11525 T17627 T17626 arg2Of "78,79",[
R11526 T17628 T17626 arg3Of ],[
R11527 T17630 T17629 arg2Of addition,In
R11528 T17632 T17633 arg1Of miR-146a,is
R11529 T17633 T17629 arg1Of is,In
R11530 T17633 T17631 arg1Of is,","
R11531 T17633 T17638 arg1Of is,and
R11532 T17636 T17633 arg2Of gene,is
R11533 T17636 T17634 arg1Of gene,an
R11534 T17636 T17635 arg1Of gene,NF-κB-dependent
R11535 T17638 T17637 arg1Of and,","
R11536 T17643 T17644 arg1Of IRAK1,and
R11537 T17644 T17639 arg1Of and,the
R11538 T17644 T17640 arg1Of and,NF-κB
R11539 T17644 T17641 arg1Of and,signalling
R11540 T17644 T17642 arg1Of and,molecules
R11541 T17644 T17646 arg1Of and,were
R11542 T17644 T17647 arg2Of and,identified
R11543 T17645 T17644 arg2Of TRAF6,and
R11544 T17647 T17638 arg2Of identified,and
R11545 T17647 T17646 arg2Of identified,were
R11546 T17647 T17648 arg1Of identified,as
R11547 T17647 T17653 arg1Of identified,[
R11548 T17647 T17656 arg1Of identified,(
R11549 T17650 T17648 arg2Of genes,as
R11550 T17650 T17649 arg1Of genes,target
R11551 T17650 T17651 arg1Of genes,of
R11552 T17652 T17651 arg2Of miR-146a,of
R11553 T17654 T17653 arg2Of 78,[
R11554 T17655 T17653 arg3Of ],[
R11555 T17657 T17656 arg2Of Figure,(
R11556 T17657 T17658 arg1Of Figure,1
R11557 T17659 T17656 arg3Of ),(
R11558 T17662 T17663 arg1Of miR-155,was
R11559 T17662 T17664 arg2Of miR-155,shown
R11560 T17664 T17660 arg1Of shown,Similarly
R11561 T17664 T17661 arg1Of shown,","
R11562 T17664 T17663 arg2Of shown,was
R11563 T17664 T17665 arg1Of shown,to
R11564 T17664 T17668 arg1Of shown,for
R11565 T17667 T17665 arg2Of transcripts,to
R11566 T17667 T17666 arg1Of transcripts,target
R11567 T17673 T17669 arg1Of IKKε,the
R11568 T17673 T17670 arg1Of IKKε,NF-κB
R11569 T17673 T17671 arg1Of IKKε,signalling
R11570 T17673 T17672 arg1Of IKKε,molecules
R11571 T17673 T17674 arg1Of IKKε,and
R11572 T17674 T17668 arg2Of and,for
R11573 T17675 T17674 arg2Of RIP1,and
R11574 T17675 T17676 arg1Of RIP1,[
R11575 T17677 T17676 arg2Of "79,80",[
R11576 T17678 T17676 arg3Of ],[
R11577 T17682 T17683 arg1Of miR-146,and
R11578 T17683 T17681 arg1Of and,both
R11579 T17683 T17685 arg1Of and,are
R11580 T17683 T17686 arg2Of and,expressed
R11581 T17684 T17683 arg2Of miR-155,and
R11582 T17686 T17685 arg2Of expressed,are
R11583 T17686 T17687 arg1Of expressed,at
R11584 T17686 T17704 arg1Of expressed,in
R11585 T17686 T17712 arg1Of expressed,[
R11586 T17687 T17703 arg1Of at,as
R11587 T17689 T17687 arg2Of levels,at
R11588 T17689 T17688 arg1Of levels,higher
R11589 T17689 T17690 arg1Of levels,in
R11590 T17693 T17691 arg1Of fibroblasts,RA
R11591 T17693 T17692 arg1Of fibroblasts,synovial
R11592 T17693 T17694 arg1Of fibroblasts,and
R11593 T17694 T17690 arg2Of and,in
R11594 T17696 T17694 arg2Of tissue,and
R11595 T17696 T17695 arg1Of tissue,synovial
R11596 T17696 T17697 arg1Of tissue,[
R11597 T17698 T17697 arg2Of "81,82",[
R11598 T17699 T17697 arg3Of ],[
R11599 T17703 T17700 arg1Of as,","
R11600 T17703 T17701 arg1Of as,as
R11601 T17703 T17702 arg1Of as,well
R11602 T17704 T17703 arg2Of in,as
R11603 T17708 T17704 arg2Of cells,in
R11604 T17708 T17705 arg1Of cells,peripheral
R11605 T17708 T17706 arg1Of cells,blood
R11606 T17708 T17707 arg1Of cells,mononuclear
R11607 T17708 T17709 arg1Of cells,of
R11608 T17711 T17709 arg2Of patients,of
R11609 T17711 T17710 arg1Of patients,RA
R11610 T17713 T17712 arg2Of 83,[
R11611 T17714 T17712 arg3Of ],[
R11612 T17715 T17716 arg1Of . miR-14,6a
R11613 T17715 T17718 arg2Of . miR-14,lso overexpre
R11614 T17718 T17679 arg1Of lso overexpre,Notably
R11615 T17718 T17680 arg1Of lso overexpre,","
R11616 T17718 T17685 modOf lso overexpre,are
R11617 T17718 T17716 arg2Of lso overexpre,6a
R11618 T17718 T17717 arg1Of lso overexpre,is a
R11619 T17718 T17719 arg1Of lso overexpre,ss
R11620 T17720 T17721 arg1Of ed i,n C
R11621 T17722 T17721 arg2Of D4+ and IL-17-p,n C
R11622 T17724 T17719 arg2Of oduci,ss
R11623 T17724 T17720 arg1Of oduci,ed i
R11624 T17724 T17722 arg1Of oduci,D4+ and IL-17-p
R11625 T17724 T17723 arg1Of oduci,r
R11626 T17724 T17725 arg1Of oduci,ng T
R11627 T17727 T17725 arg2Of lls from,ng T
R11628 T17727 T17726 arg1Of lls from,ce
R11629 T17727 T17728 arg1Of lls from,R
R11630 T17729 T17728 arg2Of A pat,R
R11631 T17730 T17728 arg3Of i,R
R11632 T17734 T17733 arg1Of polymorphism,a
R11633 T17734 T17735 arg1Of polymorphism,in
R11634 T17734 T17743 arg1Of polymorphism,was
R11635 T17734 T17745 arg2Of polymorphism,shown
R11636 T17734 T17747 arg1Of polymorphism,be
R11637 T17734 T17748 arg2Of polymorphism,associated
R11638 T17737 T17735 arg2Of 3'-UTR,in
R11639 T17737 T17736 arg1Of 3'-UTR,the
R11640 T17737 T17738 arg1Of 3'-UTR,of
R11641 T17742 T17738 arg2Of gene,of
R11642 T17742 T17739 arg1Of gene,the
R11643 T17742 T17740 arg1Of gene,miR-146a
R11644 T17742 T17741 arg1Of gene,target
R11645 T17745 T17731 arg1Of shown,Interestingly
R11646 T17745 T17732 arg1Of shown,","
R11647 T17745 T17743 arg2Of shown,was
R11648 T17745 T17744 arg1Of shown,recently
R11649 T17748 T17745 arg3Of associated,shown
R11650 T17748 T17746 arg1Of associated,to
R11651 T17748 T17747 arg2Of associated,be
R11652 T17748 T17749 arg1Of associated,with
R11653 T17748 T17757 arg1Of associated,io
R11654 T17753 T17752 arg2Of 86,[
R11655 T17754 T17752 arg3Of ],[
R11656 T17756 T17749 arg2Of 55 overexpress,with
R11657 T17756 T17750 arg1Of 55 overexpress,RA
R11658 T17756 T17751 arg1Of 55 overexpress,susceptibility
R11659 T17756 T17752 arg1Of 55 overexpress,[
R11660 T17756 T17755 arg1Of 55 overexpress,. miR-1
R11661 T17759 T17758 arg1Of ovial fibro,n in syn
R11662 T17759 T17760 arg1Of ovial fibro,bla
R11663 T17759 T17761 arg1Of ovial fibro,sts
R11664 T17759 T17763 arg1Of ovial fibro,s able
R11665 T17760 T17757 arg2Of bla,io
R11666 T17761 T17760 arg2Of sts ,bla
R11667 T17763 T17761 arg2Of s able ,sts
R11668 T17763 T17762 arg1Of s able ,wa
R11669 T17765 T17766 arg1Of pre,ven
R11670 T17767 T17766 arg2Of t the TLR and cyto,ven
R11671 T17768 T17763 arg2Of kine-induc,s able
R11672 T17768 T17764 arg1Of kine-induc,to
R11673 T17768 T17765 arg1Of kine-induc,pre
R11674 T17768 T17767 arg1Of kine-induc,t the TLR and cyto
R11675 T17768 T17769 arg1Of kine-induc,ib
R11676 T17772 T17769 arg2Of of specific matrix,ib
R11677 T17772 T17770 arg1Of of specific matrix,le expre
R11678 T17772 T17771 arg1Of of specific matrix,ssion
R11679 T17772 T17773 arg1Of of specific matrix,meta
R11680 T17772 T17774 arg1Of of specific matrix,lloprot
R11681 T17774 T17777 arg1Of lloprot,at
R11682 T17774 T17779 arg1Of lloprot,t
R11683 T17776 T17774 arg2Of s that medi,lloprot
R11684 T17776 T17775 arg1Of s that medi,einase
R11685 T17778 T17777 arg2Of e ,at
R11686 T17780 T17779 arg2Of is,t
R11687 T17781 T17779 arg3Of s,t
R11688 T17784 T17785 arg1Of miR-155,was
R11689 T17784 T17786 arg2Of miR-155,shown
R11690 T17784 T17788 arg1Of miR-155,promote
R11691 T17786 T17785 arg2Of shown,was
R11692 T17786 T17804 arg1Of shown,46
R11693 T17788 T17786 arg3Of promote,shown
R11694 T17788 T17787 arg1Of promote,to
R11695 T17788 T17795 arg1Of promote,in
R11696 T17790 T17788 arg2Of production,promote
R11697 T17790 T17789 arg1Of production,TNF
R11698 T17790 T17791 arg1Of production,","
R11699 T17794 T17791 arg2Of process,","
R11700 T17794 T17792 arg1Of process,a
R11701 T17794 T17793 arg1Of process,key
R11702 T17797 T17795 arg2Of pathogenesis,in
R11703 T17797 T17796 arg1Of pathogenesis,the
R11704 T17797 T17798 arg1Of pathogenesis,of
R11705 T17799 T17798 arg2Of RA,of
R11706 T17801 T17800 arg2Of 87,[
R11707 T17802 T17800 arg3Of ],[
R11708 T17803 T17795 arg3Of . miR-1,in
R11709 T17803 T17800 arg1Of . miR-1,[
R11710 T17804 T17816 arg1Of 46 ,mma
R11711 T17805 T17806 arg1Of and miR,-15
R11712 T17805 T17808 arg1Of and miR,re
R11713 T17808 T17804 arg2Of re,46
R11714 T17808 T17806 arg2Of re,-15
R11715 T17808 T17807 arg1Of re,5 may the
R11716 T17810 T17809 arg1Of mportant,fore be i
R11717 T17811 T17808 arg2Of negative r,re
R11718 T17811 T17810 arg1Of negative r,mportant
R11719 T17811 T17812 arg1Of negative r,eg
R11720 T17811 T17814 arg1Of negative r,nf
R11721 T17813 T17812 arg2Of ulators of i,eg
R11722 T17815 T17814 arg2Of la,nf
R11723 T17816 T17782 arg1Of mma,Moreover
R11724 T17816 T17783 arg1Of mma,","
R11725 T17818 T17817 arg1Of in RA and,tion
R11726 T17818 T17819 arg1Of in RA and,the
R11727 T17818 T17825 arg1Of in RA and,t
R11728 T17818 T17826 arg1Of in RA and,of new trea
R11729 T17821 T17819 arg2Of potential f,the
R11730 T17821 T17820 arg1Of potential f,ir
R11731 T17821 T17822 arg1Of potential f,or
R11732 T17824 T17822 arg2Of developmen,or
R11733 T17824 T17823 arg1Of developmen,the
R11734 T17825 T17816 arg2Of t ,mma
R11735 T17826 T17825 arg2Of of new trea,t
R11736 T17828 T17827 arg2Of addition,In
R11737 T17832 T17830 arg1Of expression,their
R11738 T17832 T17831 arg2Of expression,increased
R11739 T17832 T17833 arg1Of expression,in
R11740 T17832 T17836 arg1Of expression,is
R11741 T17832 T17838 arg1Of expression,useful
R11742 T17835 T17833 arg2Of patients,in
R11743 T17835 T17834 arg1Of patients,RA
R11744 T17836 T17851 arg1Of is,[
R11745 T17836 T17855 arg1Of is,but
R11746 T17838 T17836 arg2Of useful,is
R11747 T17838 T17837 arg1Of useful,potentially
R11748 T17838 T17839 arg1Of useful,as
R11749 T17841 T17839 arg2Of marker,as
R11750 T17841 T17840 arg1Of marker,a
R11751 T17841 T17842 arg1Of marker,for
R11752 T17844 T17843 arg1Of diagnosis,disease
R11753 T17844 T17845 arg1Of diagnosis,","
R11754 T17845 T17848 arg1Of ",",or
R11755 T17846 T17845 arg2Of progression,","
R11756 T17848 T17842 arg2Of or,for
R11757 T17848 T17847 arg1Of or,","
R11758 T17850 T17848 arg2Of efficacy,or
R11759 T17850 T17849 arg1Of efficacy,treatment
R11760 T17852 T17851 arg2Of 88,[
R11761 T17853 T17851 arg3Of ],[
R11762 T17855 T17827 arg1Of but,In
R11763 T17855 T17829 arg1Of but,","
R11764 T17855 T17854 arg1Of but,","
R11765 T17856 T17857 arg1Of this,will
R11766 T17856 T17858 arg1Of this,require
R11767 T17856 T17860 arg1Of this,using
R11768 T17858 T17855 arg2Of require,but
R11769 T17858 T17857 arg2Of require,will
R11770 T17858 T17860 modOf require,using
R11771 T17859 T17858 arg2Of confirmation,require
R11772 T17862 T17863 arg1Of large,and
R11773 T17864 T17863 arg2Of well-defined,and
R11774 T17865 T17860 arg2Of cohort,using
R11775 T17865 T17861 arg1Of cohort,a
R11776 T17865 T17862 arg1Of cohort,large
R11777 T17865 T17864 arg1Of cohort,well-defined

UBERON-AE

Id Subject Object Predicate Lexical cue
T17435 600-605 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T17434 1035-1041 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue
T17433 559-565 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue

GO-BP

Id Subject Object Predicate Lexical cue
T17987 1237-1249 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T17984 1284-1295 http://purl.obolibrary.org/obo/GO_0032502 denotes development
T17997 1142-1154 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T17996 1105-1119 http://purl.obolibrary.org/obo/GO_0032640 denotes TNF production
T17995 404-420 http://purl.obolibrary.org/obo/GO_0038061 denotes NF-κB signalling
T17994 241-257 http://purl.obolibrary.org/obo/GO_0038061 denotes NF-κB signalling
T17993 410-420 http://purl.obolibrary.org/obo/GO_0023052 denotes signalling
T17992 247-257 http://purl.obolibrary.org/obo/GO_0023052 denotes signalling
T17991 67-77 http://purl.obolibrary.org/obo/GO_0023052 denotes signalling

GO-MF

Id Subject Object Predicate Lexical cue
T18004 688-693 http://purl.obolibrary.org/obo/GO_0030367 denotes IL-17

GO-CC

Id Subject Object Predicate Lexical cue
T18008 706-711 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T18007 618-623 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T17445 1330-1556 Sentence denotes In addition, their increased expression in RA patients is potentially useful as a marker for disease diagnosis, progression, or treatment efficacy [88], but this will require confirmation using a large and well-defined cohort.
T17444 1066-1329 Sentence denotes Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial.
T17443 738-1065 Sentence denotes Interestingly, a polymorphism in the 3'-UTR of the miR-146a target gene was recently shown to be associated with RA susceptibility [86]. miR-155 overexpression in synovial fibroblasts was able to prevent the TLR and cytokine-inducible expression of specific matrix metalloproteinases that mediate tissue destruction in RA [81].
T17442 454-737 Sentence denotes Notably, both miR-146 and miR-155 are expressed at higher levels in RA synovial fibroblasts and synovial tissue [81,82], as well as in peripheral blood mononuclear cells of RA patients [83]. miR-146a is also overexpressed in CD4+ and IL-17-producing T cells from RA patients [84,85].
T17441 345-453 Sentence denotes Similarly, miR-155 was shown to target transcripts for the NF-κB signalling molecules IKKε and RIP1 [79,80].
T17440 183-344 Sentence denotes In addition, miR-146a is an NF-κB-dependent gene, and the NF-κB signalling molecules IRAK1 and TRAF6 were identified as target genes of miR-146a [78] (Figure 1).
T17439 0-182 Sentence denotes miR-146a/b and miR-155 are of particular interest for inflammatory signalling to NF-κB, since these miRNAs can be induced by inflammatory stimuli such as IL-1β, TNF and TLRs [78,79].
T176 0-182 Sentence denotes miR-146a/b and miR-155 are of particular interest for inflammatory signalling to NF-κB, since these miRNAs can be induced by inflammatory stimuli such as IL-1β, TNF and TLRs [78,79].
T177 183-344 Sentence denotes In addition, miR-146a is an NF-κB-dependent gene, and the NF-κB signalling molecules IRAK1 and TRAF6 were identified as target genes of miR-146a [78] (Figure 1).
T178 345-453 Sentence denotes Similarly, miR-155 was shown to target transcripts for the NF-κB signalling molecules IKKε and RIP1 [79,80].
T179 454-737 Sentence denotes Notably, both miR-146 and miR-155 are expressed at higher levels in RA synovial fibroblasts and synovial tissue [81,82], as well as in peripheral blood mononuclear cells of RA patients [83]. miR-146a is also overexpressed in CD4+ and IL-17-producing T cells from RA patients [84,85].
T180 738-1065 Sentence denotes Interestingly, a polymorphism in the 3'-UTR of the miR-146a target gene was recently shown to be associated with RA susceptibility [86]. miR-155 overexpression in synovial fibroblasts was able to prevent the TLR and cytokine-inducible expression of specific matrix metalloproteinases that mediate tissue destruction in RA [81].
T181 1066-1329 Sentence denotes Moreover, miR-155 was shown to promote TNF production, a key process in the pathogenesis of RA [87]. miR-146 and miR-155 may therefore be important negative regulators of inflammation in RA and their potential for the development of new treatments is substantial.
T182 1330-1556 Sentence denotes In addition, their increased expression in RA patients is potentially useful as a marker for disease diagnosis, progression, or treatment efficacy [88], but this will require confirmation using a large and well-defined cohort.

simple1

Id Subject Object Predicate Lexical cue
T18029 1179-1186 Protein denotes miR-155
T18028 1105-1108 Protein denotes TNF
T18027 1076-1083 Protein denotes miR-155
T18026 875-882 Protein denotes miR-155
T18025 789-797 Protein denotes miR-146a
T18024 688-693 Protein denotes IL-17
T18023 679-682 Protein denotes CD4
T18022 645-653 Protein denotes miR-146a
T18021 480-487 Protein denotes miR-155
T18020 440-444 Protein denotes RIP1
T18019 431-435 Protein denotes IKKε
T18018 356-363 Protein denotes miR-155
T18017 319-327 Protein denotes miR-146a
T18016 278-283 Protein denotes TRAF6
T18015 268-273 Protein denotes IRAK1
T18014 196-204 Protein denotes miR-146a
T18013 161-164 Protein denotes TNF
T18012 154-159 Protein denotes IL-1β
T18011 15-22 Protein denotes miR-155
T18010 9-10 Protein denotes b
T18009 0-8 Protein denotes miR-146a

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T18774 662-675 Gene_expression denotes overexpressed
T18773 492-501 Gene_expression denotes expressed
T18772 211-226 Regulation denotes NF-κB-dependent
T18762 1179-1186 Protein denotes miR-155
T18761 1105-1108 Protein denotes TNF
T18760 1076-1083 Protein denotes miR-155
T18759 875-882 Protein denotes miR-155
T18758 789-797 Protein denotes miR-146a
T18757 688-693 Protein denotes IL-17
T18756 679-682 Protein denotes CD4
T18755 645-653 Protein denotes miR-146a
T18754 480-487 Protein denotes miR-155
T18753 440-444 Protein denotes RIP1
T18752 431-435 Protein denotes IKKε
T18751 356-363 Protein denotes miR-155
T18750 319-327 Protein denotes miR-146a
T18749 278-283 Protein denotes TRAF6
T18748 268-273 Protein denotes IRAK1
T18747 196-204 Protein denotes miR-146a
T18746 161-164 Protein denotes TNF
T18745 154-159 Protein denotes IL-1β
T18744 15-22 Protein denotes miR-155
T18743 9-10 Protein denotes b
T18742 0-8 Protein denotes miR-146a
T18780 1109-1119 Gene_expression denotes production
T18779 1097-1104 Positive_regulation denotes promote
T18778 883-897 Positive_regulation denotes overexpression
T18777 883-897 Gene_expression denotes overexpression
T18776 694-703 Gene_expression denotes producing
T18775 662-675 Positive_regulation denotes overexpressed
R12435 T18747 T18772 themeOf miR-146a,NF-κB-dependent
R12436 T18754 T18773 themeOf miR-155,expressed
R12437 T18755 T18774 themeOf miR-146a,overexpressed
R12438 T18757 T18776 themeOf IL-17,producing
R12439 T18759 T18777 themeOf miR-155,overexpression
R12440 T18761 T18780 themeOf TNF,production
R12446 T18774 T18775 themeOf overexpressed,overexpressed
R12447 T18777 T18778 themeOf overexpression,overexpression
R12448 T18780 T18779 themeOf production,promote

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T18546 1097-1104 Positive_regulation denotes promote
T18545 1109-1119 Gene_expression denotes production
T18544 883-897 Positive_regulation denotes overexpression
T18543 798-804 Binding denotes target
T18542 694-703 Gene_expression denotes producing
T18541 662-675 Gene_expression denotes overexpressed
T18540 492-501 Gene_expression denotes expressed
T18539 114-121 Positive_regulation denotes induced
T18529 1179-1186 Protein denotes miR-155
T18528 1105-1108 Protein denotes TNF
T18527 1076-1083 Protein denotes miR-155
T18526 875-882 Protein denotes miR-155
T18525 789-797 Protein denotes miR-146a
T18524 688-693 Protein denotes IL-17
T18523 679-682 Protein denotes CD4
T18522 645-653 Protein denotes miR-146a
T18521 480-487 Protein denotes miR-155
T18520 440-444 Protein denotes RIP1
T18519 431-435 Protein denotes IKKε
T18518 356-363 Protein denotes miR-155
T18517 319-327 Protein denotes miR-146a
T18516 278-283 Protein denotes TRAF6
T18515 268-273 Protein denotes IRAK1
T18514 196-204 Protein denotes miR-146a
T18513 161-164 Protein denotes TNF
T18512 154-159 Protein denotes IL-1β
T18511 15-22 Protein denotes miR-155
T18510 9-10 Protein denotes b
T18509 0-8 Protein denotes miR-146a
R12357 T18512 T18539 themeOf IL-1β,induced
R12358 T18513 T18539 causeOf TNF,induced
R12359 T18521 T18540 themeOf miR-155,expressed
R12360 T18522 T18541 themeOf miR-146a,overexpressed
R12361 T18524 T18542 themeOf IL-17,producing
R12362 T18525 T18543 themeOf miR-146a,target
R12363 T18526 T18544 themeOf miR-155,overexpression
R12364 T18528 T18545 themeOf TNF,production
R12371 T18545 T18546 themeOf production,promote

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T18867 454-545 Gene_expression denotes Notably, both miR-146 and miR-155 are expressed at higher levels in RA synovial fibroblasts
T18865 954-1064 Gene_expression denotes cytokine-inducible expression of specific matrix metalloproteinases that mediate tissue destruction in RA [81]
T18864 984-1064 Regulation denotes of specific matrix metalloproteinases that mediate tissue destruction in RA [81]
T18863 645-736 Positive_regulation denotes miR-146a is also overexpressed in CD4+ and IL-17-producing T cells from RA patients [84,85]
T18862 645-736 Gene_expression denotes miR-146a is also overexpressed in CD4+ and IL-17-producing T cells from RA patients [84,85]
T18861 875-921 Gene_expression denotes miR-155 overexpression in synovial fibroblasts
T18860 875-921 Positive_regulation denotes miR-155 overexpression in synovial fibroblasts
T18857 1343-1369 Positive_regulation denotes their increased expression
T18852 161-164 Protein denotes TNF
T18851 1179-1186 Protein denotes miR-155
T18847 0-10 Protein denotes miR-146a/b
T18845 645-653 Protein denotes miR-146a
T18844 717-719 Protein denotes RA
T18843 1057-1064 Protein denotes RA [81]
T18841 211-226 Protein denotes NF-κB-dependent
T18839 984-1064 Protein denotes of specific matrix metalloproteinases that mediate tissue destruction in RA [81]
T18838 208-231 Protein denotes an NF-κB-dependent gene
T18836 237-273 Entity denotes the NF-κB signalling molecules IRAK1
T18835 875-882 Protein denotes miR-155
T18834 400-435 Protein denotes the NF-κB signalling molecules IKKε
T18833 480-487 Protein denotes miR-155
T18832 81-86 Protein denotes NF-κB
T18831 303-343 Protein denotes target genes of miR-146a [78] (Figure 1)
T18830 400-435 Entity denotes the NF-κB signalling molecules IKKε
T18829 278-283 Protein denotes TRAF6
T18828 319-332 Protein denotes miR-146a [78]
T18827 901-921 Entity denotes synovial fibroblasts
T18826 1076-1083 Protein denotes miR-155
T18825 679-736 Entity denotes CD4+ and IL-17-producing T cells from RA patients [84,85]
T18824 1167-1174 Entity denotes miR-146
T18822 384-395 Protein denotes transcripts
T18821 122-159 Protein denotes by inflammatory stimuli such as IL-1β
T18818 404-409 Protein denotes NF-κB
T18816 0-10 Protein denotes miR-146a/b
T18815 237-273 Protein denotes the NF-κB signalling molecules IRAK1
T18814 805-809 Protein denotes gene
T18813 356-363 Protein denotes miR-155
T18812 522-545 Entity denotes RA synovial fibroblasts
T18810 9-10 Protein denotes b
T18809 789-797 Protein denotes miR-146a
T18807 1253-1255 Protein denotes RA
T18806 468-475 Entity denotes miR-146
T18805 522-524 Protein denotes RA
T18802 1373-1375 Protein denotes RA
T18801 15-22 Protein denotes miR-155
T18796 196-204 Protein denotes miR-146a
T18795 440-444 Protein denotes RIP1
T18794 241-246 Protein denotes NF-κB
T18791 589-643 Entity denotes peripheral blood mononuclear cells of RA patients [83]
T18789 1158-1160 Protein denotes RA
T18788 851-853 Protein denotes RA
T18787 627-629 Protein denotes RA
R12454 T18833 T18867 themeOf miR-155,"Notably, both miR-146 and miR-155 are expressed at higher levels in RA synovial fibroblasts"
R12455 T18835 T18860 themeOf miR-155,miR-155 overexpression in synovial fibroblasts
R12456 T18835 T18861 themeOf miR-155,miR-155 overexpression in synovial fibroblasts
R12457 T18839 T18864 causeOf of specific matrix metalloproteinases that mediate tissue destruction in RA [81],of specific matrix metalloproteinases that mediate tissue destruction in RA [81]
R12458 T18839 T18865 themeOf of specific matrix metalloproteinases that mediate tissue destruction in RA [81],cytokine-inducible expression of specific matrix metalloproteinases that mediate tissue destruction in RA [81]
R12459 T18845 T18862 themeOf miR-146a,"miR-146a is also overexpressed in CD4+ and IL-17-producing T cells from RA patients [84,85]"
R12460 T18845 T18863 themeOf miR-146a,"miR-146a is also overexpressed in CD4+ and IL-17-producing T cells from RA patients [84,85]"

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T18622 1097-1104 Positive_regulation denotes promote
T18621 1109-1119 Gene_expression denotes production
T18620 1105-1108 Protein denotes TNF
T18619 934-941 Negative_regulation denotes prevent
T18618 973-983 Gene_expression denotes expression
T18617 1003-1021 Protein denotes metalloproteinases
T18616 789-797 Protein denotes miR-146a
T18615 688-703 Gene_expression denotes IL-17-producing
T18614 662-675 Positive_regulation denotes overexpressed
T18613 679-683 Protein denotes CD4+
T18612 645-653 Protein denotes miR-146a
T18611 492-501 Gene_expression denotes expressed
T18610 492-501 Gene_expression denotes expressed
T18609 480-487 Protein denotes miR-155
T18608 468-475 Protein denotes miR-146
T18607 445-451 Entity denotes [79,80
T18606 421-444 Protein denotes molecules IKKε and RIP1
T18605 404-409 Protein denotes NF-κB
T18604 319-327 Protein denotes miR-146a
T18603 278-283 Protein denotes TRAF6
T18602 268-273 Protein denotes IRAK1
T18601 241-246 Protein denotes NF-κB
T18600 211-216 Protein denotes NF-κB
T18599 196-204 Protein denotes miR-146a
T18598 161-164 Protein denotes TNF
T18597 154-159 Protein denotes IL-1β
T18596 81-86 Protein denotes NF-κB
T18595 15-22 Protein denotes miR-155
T18594 0-10 Protein denotes miR-146a/b
R12394 T18607 T18605 SiteParent "[79,80",NF-κB
R12395 T18607 T18606 SiteParent "[79,80",molecules IKKε and RIP1
R12396 T18608 T18610 themeOf miR-146,expressed
R12397 T18609 T18611 themeOf miR-155,expressed
R12398 T18612 T18614 themeOf miR-146a,overexpressed
R12399 T18613 T18615 themeOf CD4+,IL-17-producing
R12400 T18617 T18618 themeOf metalloproteinases,expression
R12401 T18618 T18619 themeOf expression,prevent
R12402 T18620 T18621 themeOf TNF,production
R12403 T18621 T18622 themeOf production,promote

test3

Id Subject Object Predicate Lexical cue
T17418 1359-1369 Gene_expression denotes expression
T17417 1179-1186 Protein denotes miR-155
T17416 1109-1119 Gene_expression denotes production
T17415 1105-1108 Protein denotes TNF
T17414 1097-1104 Positive_regulation denotes promote
T17413 1076-1083 Protein denotes miR-155
T17412 875-882 Protein denotes miR-155
T17411 789-797 Protein denotes miR-146a
T17410 694-703 Gene_expression denotes producing
T17409 688-693 Protein denotes IL-17
T17408 679-682 Protein denotes CD4
T17407 645-653 Protein denotes miR-146a
T17406 480-487 Protein denotes miR-155
T17405 440-444 Protein denotes RIP1
T17404 431-435 Protein denotes IKKε
T17403 356-363 Protein denotes miR-155
T17402 319-327 Protein denotes miR-146a
T17401 278-283 Protein denotes TRAF6
T17400 268-273 Protein denotes IRAK1
T17399 196-204 Protein denotes miR-146a
T17398 161-164 Protein denotes TNF
T17397 154-159 Protein denotes IL-1β
T17396 114-121 Positive_regulation denotes induced
T17395 15-22 Protein denotes miR-155
T17394 9-10 Protein denotes b
T17393 0-8 Protein denotes miR-146a
T17382 1179-1186 Protein denotes miR-155
T17381 1105-1108 Protein denotes TNF
T17380 1076-1083 Protein denotes miR-155
T17379 875-882 Protein denotes miR-155
T17378 789-797 Protein denotes miR-146a
T17377 688-693 Protein denotes IL-17
T17376 679-682 Protein denotes CD4
T17375 645-653 Protein denotes miR-146a
T17374 480-487 Protein denotes miR-155
T17373 440-444 Protein denotes RIP1
T17372 431-435 Protein denotes IKKε
T17371 356-363 Protein denotes miR-155
T17370 319-327 Protein denotes miR-146a
T17369 278-283 Protein denotes TRAF6
T17368 268-273 Protein denotes IRAK1
T17367 196-204 Protein denotes miR-146a
T17366 161-164 Protein denotes TNF
T17365 154-159 Protein denotes IL-1β
T17364 15-22 Protein denotes miR-155
T17363 9-10 Protein denotes b
T17362 0-8 Protein denotes miR-146a
R11392 T17409 T17410 themeOf IL-17,producing
R11393 T17413 T17414 causeOf miR-155,promote
R11394 T17415 T17416 themeOf TNF,production
R11395 T17416 T17414 themeOf production,promote